Search for content and authors


Agnieszka Burzyńska ,  Wiesław Pucko ,  Teresa Ryznar ,  Jerzy Winiarski 

Pharmaceutical Research Institute (IF), Rydygiera 8, Warszawa 01-793, Poland


Vitamin D is essential for the absorption and utilization of calcium and phosphate and aids in the mobilization of bone calcium and maintenance of serum calcium concentrations. 25-Hydroxyvitamin D3 is the major circulating metabolite of vitamin D3.1

It is produced in the liver and is the best indicator of the body's vitamin D stores. It is effective in the treatment of Rickets and Osteomalacia, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties and it is used in clinical situations.

We described herein synthesis of calcifediol from vitamin D2 based on the Barton-Hesse and their collaborators2,3 strategy with some modifications of this pathway. Our synthesis of calcifediol can be suitable for the large scale preparation of this important vitamin D analogue.

1 Deluca, H.F.; Paaren,H.F.; Schnoes, H.K. Top. Curr. Chem. 1979, 83, and references there citted.

2 Andrews, D.R.; Barton, D.H.R.; HesseR.H.; Pechet, M.M. J. Org. Chem. 1986, 51, 4819.

3Manchand, P.S.; Yiannikouros, G.P.; Belica, P.S.; Madan, P. J. Org. Chem. 1995, 60, 6574.


Legal notice
  • Legal notice:

Related papers

Presentation: Poster at V Multidyscyplinarna Konferencja Nauki o Leku, by Agnieszka Burzyńska
See On-line Journal of V Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2006-01-25 09:24
Revised:   2009-06-07 00:44